Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stephen

Showing results (221-230 of 266) with videos related to

Pageof 27
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 13, 2014
Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffoldPaul Galatsis, Jaclyn L Henderson, Bethany L Kormos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Randomized, controlled trial of yoga in women with breast cancer undergoing radiotherapyKavita D Chandwani, George Perkins, Hongasandra Ramarao Nagendra, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2024
Determining KRAS4B-Targeting Compound Specificity by Top-Down Mass SpectrometryRobert A D'Ippolito, Grace M Scheidemantle, Dana Rabara, et al.
Nucleic Acids Research|February 2, 2006
Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteinsMargareta Cruceanu, Maria A Urbaneja, Catherine V Hixson, et al.
ACS Omega|January 21, 2020
PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras ActivityFarid A Siddiqui, Catharina Alam, Petja Rosenqvist, et al.
Prenatal Diagnosis|July 13, 2006
Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndromeWendy Y Craig, James E Haddow, Glenn E Palomaki, et al.
The Journal of Biological Chemistry|June 5, 2025
Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraintsPatrick Alexander, Albert H Chan, Dana Rabara, et al.
The Journal of Biological Chemistry|January 18, 2024
Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by <sup>31</sup>P NMRAlok K Sharma, Jun Pei, Yue Yang, et al.
Journal of Cancer Survivorship : Research and Practice|June 18, 2011
Physical activity among adult survivors of childhood lower-extremity sarcomaMeredith A Wampler, Mary Lou Galantino, Sujuan Huang, et al.
The Journal of Biological Chemistry|October 29, 2002
Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbitsGuorong Xu, Lu-Xing Pan, Hai Li, et al.
Pageof 27

Showing results (221-230 of 266) with videos related to

Sort By:
Pageof 27
Bioorganic & Medicinal Chemistry Letters|August 13, 2014
Kinase domain inhibition of leucine rich repeat kinase 2 (LRRK2) using a [1,2,4]triazolo[4,3-b]pyridazine scaffoldPaul Galatsis, Jaclyn L Henderson, Bethany L Kormos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2014
Randomized, controlled trial of yoga in women with breast cancer undergoing radiotherapyKavita D Chandwani, George Perkins, Hongasandra Ramarao Nagendra, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 25, 2024
Determining KRAS4B-Targeting Compound Specificity by Top-Down Mass SpectrometryRobert A D'Ippolito, Grace M Scheidemantle, Dana Rabara, et al.
Nucleic Acids Research|February 2, 2006
Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteinsMargareta Cruceanu, Maria A Urbaneja, Catherine V Hixson, et al.
ACS Omega|January 21, 2020
PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras ActivityFarid A Siddiqui, Catharina Alam, Petja Rosenqvist, et al.
Prenatal Diagnosis|July 13, 2006
Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndromeWendy Y Craig, James E Haddow, Glenn E Palomaki, et al.
The Journal of Biological Chemistry|June 5, 2025
Biophysical and structural analysis of KRAS switch-II pocket inhibitors reveals allele-specific binding constraintsPatrick Alexander, Albert H Chan, Dana Rabara, et al.
The Journal of Biological Chemistry|January 18, 2024
Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by <sup>31</sup>P NMRAlok K Sharma, Jun Pei, Yue Yang, et al.
Journal of Cancer Survivorship : Research and Practice|June 18, 2011
Physical activity among adult survivors of childhood lower-extremity sarcomaMeredith A Wampler, Mary Lou Galantino, Sujuan Huang, et al.
The Journal of Biological Chemistry|October 29, 2002
Regulation of the farnesoid X receptor (FXR) by bile acid flux in rabbitsGuorong Xu, Lu-Xing Pan, Hai Li, et al.
Pageof 27